Development and validation of a LC-ESI-MS/MS method for simultaneous whole blood analysis of 51 new psychoactive substances

Maria Cristina Franck; Maristela Goldnadel Monteiro; Renata Pereira Limberger

doi:10.22456/2527-2616.97423

Authors

Maria Cristina Franck Toxicology Division of the Laboratory of Criminal Investigation of IGP-RS; Postgraduate Program in Pharmaceutical Sciences - Faculty of Pharmacy - UFRGS
Maristela Goldnadel Monteiro Non Communicable Diseases and Mental Health - Pan American Health Organization
Renata Pereira Limberger Postgraduate Program in Pharmaceutical Sciences - Faculty of Pharmacy - UFRGS

DOI:

https://doi.org/10.22456/2527-2616.97423

Keywords:

Bioanalytical method, Forensic toxicology, Whole blood, Tandem mass spectrometry

Abstract

In recent years, there has been a great increase in seizures and forensic analysis of new psychotropic substances (NPS) in the state of Rio Grande do Sul. The analysis of these compounds needs to be performed in biological samples in cases of violent deaths. A sensitive and reliable liquid chromatography-tandem mass spectrometry with electrospray ionization interface (LC-ESI-MS/MS) method was developed and validated for qualitative analysis of 51 NPS in whole blood forensic samples. Synthetic cathinones, phenethylamines, opioids, tryptamines, synthetic cannabinoids, and other hallucinogens and stimulants were included in the method. The validation parameters assessed were speciﬁcity, limit of detection, retention time precision, and matrix effect. Drug free pools (n=6) were used for validation, including post mortem samples as well as from living individuals. Adulterants, pharmaceuticals, metabolites, and other illicit drugs, totalling 39 compounds, were analyzed and no interference was noticed. The detection limits obtained were suitable for evaluation at recreational and non-fatal levels of consumption, mostly. The results revealed an appropriate matrix effect in 24 out of 51 substances tested, indicating the potential for future quantitative analysis with this method for these drugs. The developed and validated method is easy to implement, fast, with low cost, and suitable for use in routine forensic toxicology laboratory analysis.

Downloads

Download data is not yet available.

References

United Nations Office on Drugs and Crime (UNODC). World Drug Report 2019. Vienna, Austria, 2019. 90p.

European Monitoring Centre for Drugs and Drug Addiction. Technical Report. An analysis of post mortem toxicology practices in drug-related death cases in Europe, 2019.

Franck MC, Meneghini LZ, Rossato LG, Limberger RP, Froehlich PE. Development and validation of an LC-UV method for quantitation of 4-bromo2,5dimethoxyamphetamine (DOB), 4-bromo2,5dimethoxyphenetylamine (2C-B), methylphenidate, fenproporex and amfepramone. Chromatographia Supplement. 2009; 69: S143-8.

Correa PS, Gris LRS, Wegner PB, Bettoni CC, Baggio EV, Carpes MJS. Caracterização de designer drugs apreendidas no estado do Rio Grande do Sul. In: Inter Forensics - Conferência Internacional de Ciências Forenses, May 23-25, 2017, Brasília, Brazil.

Nunes CC, Scolmeister D, Wegner PB, Silva SM, Bettoni CC, Gris LRS, et al. Results obtained in the analysis of materials submitted to ecstasy research in RS in years 2012 and 2013. In: ToxiLatin 1º Congresso latinoamericano de toxicologia clínico-laboratorial, April 27- 30, 2014, Porto Alegre, Brazil.

Nunes CC, Wegner PB, Gris LRS, Correa PS. Synthetic drugs profile in Rio Grande do Sul in 2015 and its implications in use by vehicle drivers. In: 21 st International council on alcohol, drugs and traffic safety conference, October 16-19, 2016, Gramado, Brazil.

Scientific Working Group for the Analysis of Seized Drugs (SWGDRUG). Recommendations version 8. USA, 2019. 83p.

Marinetti LJ, Antonides HM. Analysis of synthetic cathinones commonly found in bath salts in human performance and post mortem toxicology: method development, drug distribution and interpretation of results. J Anal Toxicol, 2013;37:135-146.

United Nations Office on Drugs and Crime (UNODC). Guidance for the validation of analytical methodology and calibration of equipment used for testing of illicit drugs in seized materials and biological specimens. Vienna, Austria, 2009. 76p.

Brazil. Agência Nacional de Vigilância Sanitária. RDC n° 27 de 17 de maio de 2012. Requisitos mínimos para validação de métodos bioanalíticos, Diário Oficial da União: Brasília.

Moffat AC, Osselton MD, Widdop B, Watts J. Clarke´s analysis of drugs and poisons in pharmaceuticals, body fluids and post mortem material. 4 th ed. Pharmaceutical Press: London; 2011.

Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A. Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Critical Care, 2012;16:R136.

European Commission. Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Official Journal, 2002;L221:8- 36.

Iamarino LZ, Oliveira MC, Antunes MM, Oliveira M, Rodrigues RO, Zanin CICB, et al. Nitritos e nitratos em produtos cárneos enlatados e/ou embutidos. Gestão em Foco, 2015;7:246-251.

Kyriakou C, Marinelli E, Frati P, Santurro A, Afxentiou M, Zaami S, et al. NBOMe: new potent hallucinogens – pharmacology, analytical methods, toxicities, fatalities: a review. Eur Rev Med Pharmacol Sci, 2015;19:3270-3281.

Suzuki J, Dekker MA, Valenti ES, Arbelo FAC, Correa AM, Poklis JL, et al. Toxicities associated with NBOMe ingestion, a novel class of potent hallucinogens: a review of the literature. Psychosomatics, 2015;56(2):129-139.

Wood DM, Sedefov R, Cunningham A, Dargan PI. Prevalence of use and acute toxicity associated with the use of NBOMe drugs. Clin Toxicol, 2015;(53)85.

Kerrigan S, Mott A, Jatzlau B, Ortiz F, Perrella L, Martin S, et al. Designer psychostimulants in urine by liquid chromatography-tandem mass spectrometry. J. Forensic Sci, 2014;59(1):175-183.

Fagiola M, Hahn T, Avella J. Screening of novel psychoactive substances in post mortem matrices by liquid chromatography-tandem mass spectrometry (LCMS-MS). J Anal Toxicol, 2018;42(8):562-569.

Ong RS, Kappatos DC, Russell SGG, Poulsen HA, Banister SD, Gerona RR, et al. Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines and cannabinoids in human whole blood by LC-MS/MS - A New Zealand perspective of use in 2018. Drug Test Anal., 2019. doi: 10.1002/dta.2697.

Fang N, Yu S, Ronis MJ, Badger TM. Matrix effects break the LC behavior rule for analytes in LC-MS/MS analysis of biological samples. Exp Biol Med, 2015;240:488-497.

Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLCMS/MS. Anal. Chem., 2003;75(13):3019-3030.

Rudzki PJ, Gniazdowska E, Buś-Kwaśnik K. Quantitative evaluation of the matrix effect in bioanalytical methods based on LC-MS: a comparison of two approaches. J Pharmaceut Biomed, 2018. DOI: 10.1016/j.pba.2018.03.052.

Elliott S, Sedefov R, Evans-Brown M. Assessing the toxicological significance of new psychoactive substances in fatalities. Drug Test Anal., 2017;10:120- 126.